<DOC>
	<DOC>NCT02737592</DOC>
	<brief_summary>To evaluate the safety of a personal lubricant when used at least four times weekly for two weeks (including at least twice weekly during sexual intercourse for subjects with monogamous male partners), in a population consisting of healthy females.</brief_summary>
	<brief_title>A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<criteria>no participation in a similar study 2weeks prior may be postmenopausal or have had a hysterectomy if sexually active, and of child bearing potential, subjects is using adequate nonbarrier method of birth control free from any vaginal disorders sexually active and in a monogamous, heterosexual relationship, and whose male partner is willing and able to give informed consent and agrees to engage in sexual intercourse at least twice each week during the twoweek study or is not sexually active personal lubricant user and agrees to replace her usual personal lubricant with the investigational product can start regardless of where they are in their cycles agrees to use the provided investigational product at least four time weekly over the two week study period exhibits no clinically significant evidence of vulvar or vaginal irritation, as determined by a study doctor, and no reports of sensory irritation at the baseline exam willing to refrain from introducing any new vaginal products, or using vaginal medications or local contraceptives during study agrees to refrain from douching or using any medications, powder, lotions or personal care products in the vulvar or perianal area willing to use a urine pregnancy test provided to them at baseline and on third visit standard medical history form on file signed informed consent completed HIPAA dependable and able to follow directions as outlined receives a score of 0 or 0.5 for erythema and edema; and 0 for sensorial irritation (burning, stinging, itching and dryness) during the first examination. pregnant, nursing or planning a pregnancy currently using or has used within two weeks prior to the study initiation, any systemic or topical corticosteroids, vasoconstrictors, antibiotics, antiinflammatories or antihistamines known allergies to vaginal or any cosmetic products reports history of recurrent bladder, vaginal infections or incontinence exhibits or reports gynecologic abnormalities or has had vaginitis within 60 days prior to study initiation uses a vaginal ring, diaphram or cervical/vault caps, condoms, or condoms with spermicide as a means of contraception participated in a study involving the vaginal area or in an investigational systemic drug study within two weeks of study initiation receives a score higher than 0/5 for erythema, edema or &gt;0 for burning, stinging, or itching, during first examination or shows any other sign of mucosal irregularities</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>